I think you would be astounded by the size of the TAVR market even when it was restricted older population. Edwards Life Science is able to get to a market cap of 40B USD on TAVR alone bu all accounts, our tissue is far superior and we have SAVR with an outstanding 1st patient outcome. Market like you is very cynical but I think the market is wrong.
- Forums
- ASX - By Stock
- AVR
- Ann: AGM CEO Presentation
Ann: AGM CEO Presentation, page-16
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.14 |
Change
0.000(0.00%) |
Mkt cap ! $277.7M |
Open | High | Low | Value | Volume |
$13.33 | $13.91 | $13.14 | $302.2K | 22.46K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 299 | $13.14 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.49 | 35 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 299 | 13.140 |
4 | 2791 | 13.000 |
2 | 67 | 12.900 |
1 | 1000 | 12.500 |
1 | 10000 | 12.000 |
Price($) | Vol. | No. |
---|---|---|
13.490 | 35 | 1 |
13.500 | 750 | 1 |
13.880 | 200 | 1 |
14.000 | 3000 | 1 |
14.100 | 100 | 1 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online